Elinor Karlsson to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications Elinor Karlsson has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.280
-
Karlsson E, Veenstra C, G?rsj? J, Nordenskj?ld B, Fornander T, St?l O. PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer. J Cancer Res Clin Oncol. 2019 Mar; 145(3):599-607.
Score: 0.151
-
Bostner J, Karlsson E, Pandiyan MJ, Westman H, Skoog L, Fornander T, Nordenskj?ld B, St?l O. Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit. Breast Cancer Res Treat. 2013 Jan; 137(2):397-406.
Score: 0.100
-
Bostner J, Karlsson E, Eding CB, Perez-Tenorio G, Franz?n H, Konstantinell A, Fornander T, Nordenskj?ld B, St?l O. S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts. Endocr Relat Cancer. 2015 Jun; 22(3):331-43.
Score: 0.030